Pentamidine Inhibits Ovarian Cancer Cell Proliferation and Migration by Maintaining Stability of PTEN in vitro

Purpose: Pentamidine is an anti-protozoal cationic aromatic diamidine drug and has been reported to exhibit anticancer properties. We aimed to identify the effect of pentamidine on proliferation and migration of human ovarian cancer (OC) cell lines and the related mechanisms. Methods: HO8910 and Caov3 ovarian cancer cells were treated with pentamidine. MTS and colony formation assays were used to detect the proliferation ability of cells. The migration of cells was detected using wound healing and transwell assays. The protein levels of PTEN, phosphorylated Akt, Akt, N-cadherin, E-cadherin and snail were detected by Western blot-ting. Immunoprecipitation and Western blotting were used to detect ubiquitination levels of PTEN. Results: Our findings revealed that pentamidine inhibited both proliferation and migration of OC cells. Further investigation found that pentamidine increased the protein expression of PTEN and reduced phosphorylation levels of AKT in OC cells. Pentamidine treatment modulated PTEN stability through the ubiquitin/proteasome pathway. In addition, pentami-dine inhibited the expression of N-cadherin and snail, and increased E-cadherin expression in a dose-dependent manner. Conclusion: Pentamidine is involved in the maintenance of PTEN protein stability and suppresses proliferation and migration of OC cells.

Automated summary

Pentamidine inhibits proliferation and migration of human ovarian cancer cells by increasing PTEN protein expression, reducing phosphorylation levels of Akt, and modulating PTEN stability.